These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3751444)

  • 1. Low-dose cytosine arabinoside in myelodysplastic syndromes.
    Martiat P; Mineur P; Ferrant A; Michaux JL
    Acta Clin Belg; 1986; 41(2):83-8. PubMed ID: 3751444
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Browman G; Walker I; Grunwald H; D'Arrigo P; Stein A
    Am J Hematol; 1986 Oct; 23(2):131-4. PubMed ID: 3529939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
    Chomienne C; Najean Y; Degos L; Thomas G; Baumelou E; Calvo F; Casassus P; Ciccone F; Fenaux P; Gris JC
    Acta Haematol; 1987; 78 Suppl 1():109-15. PubMed ID: 3124432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose Ara-C for patients with myelodysplastic syndromes.
    Powell BL; Capizzi RL; Jackson DV; Richards F; Muss HB; Lyerly ES; Rosenbaum DL; Connelly RA; Buss DH; Bearden JD
    Leukemia; 1988 Mar; 2(3):153-6. PubMed ID: 3347093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose cytosine arabinoside in myelodysplastic syndromes.
    Mineur P; Martiat P; Ferrant A; Michaux JL
    Acta Clin Belg; 1989; 44(1):62-3. PubMed ID: 2763785
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome.
    Tanaka M; Kanamori H; Yamaji S; Mishima A; Fujita H; Fujisawa S; Murata T; Koharazawa H; Matsuzaki M; Mohri H
    Anticancer Drugs; 1999 Mar; 10(3):289-91. PubMed ID: 10327034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose cytosine arabinoside in patients with acute myeloblastic leukemia and myelodysplastic syndrome.
    Heyll A; Aul C; Heyll U; Schneider W
    Haematol Blood Transfus; 1987; 30():322-5. PubMed ID: 3476364
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of myelodysplastic syndrome using continual subcutaneous infusion of low doses of cytosine arabinoside].
    Vozobulová V; Koza V; Cepelák V; Neuwirtová R; Masek Z
    Vnitr Lek; 1990 May; 36(5):483-8. PubMed ID: 2375080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose cytosine arabinoside in the treatment of the primary myelodysplastic syndrome.
    Pluta A; Kowalewski J; Kurowska M; Spiewak H; Hus M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):787-91. PubMed ID: 1713883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.
    Murray M; Sarsfield P; Lawlor E; McCann SR
    Ir J Med Sci; 1988 Jul; 157(7):238-41. PubMed ID: 3170148
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral Acute Anterior Uveitis during Chemotherapy with Cytosine Arabinoside with a Total Cumulative Dose of 24 000 mg for Myelodysplastic Syndrome.
    Häller CNI; Sadeghi Y; Benmachiche M; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2020 Apr; 237(4):425-426. PubMed ID: 32330986
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia.
    Maiolo AT; Foa P; Cortellaro M; Lambertenghi-Deliliers G; Colantoni A; Cesana B; Castoldi GL; Cazzola M; Giordano M; Riccardi A
    Haematologica; 1987; 72(1):61-5. PubMed ID: 3108098
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of low-dose cytarabine therapy in myelodysplastic syndromes.
    el-Mangoush M; Singh NK
    J Assoc Physicians India; 1992 Jul; 40(7):452-4. PubMed ID: 1484026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloblastic leukemias and myelodysplasias: treatment with low doses of aracytine].
    Pignon B; Blaise AM; Boilletot A; Herbrecht R; Rozenbaum A; Flesch M; Audhuy B; Barats JC
    Nouv Rev Fr Hematol (1978); 1986; 28(6):345-8. PubMed ID: 3470706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.
    Natarajan-Amé S; Park S; Ades L; Vey N; Guerci-Bresler A; Cahn JY; Etienne G; Bordessoule D; Ravoet C; Legros L; Cheze S; Stamatoullas A; Berger E; Schmidt A; Charbonnier A; Chaury MP; Braun T; Fenaux P; Dreyfus F;
    Br J Haematol; 2012 Jul; 158(2):232-237. PubMed ID: 22571447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
    Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
    Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.
    Takabayashi M; Sakai R; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2003 May; 44(5):891-2. PubMed ID: 12802934
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose cytosine arabinoside therapy in myelodysplastic syndrome and acute myeloid leukemia.
    Katayama N; Tanaka I; Minami N; Shirakawa S
    Jpn J Clin Oncol; 1987 Jun; 17(2):117-21. PubMed ID: 3475489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of a case of myelodysplastic syndrome with partial myeloperoxidase deficiency to continuous infusion of low-dose cytosine arabinoside.
    Cheong SK
    Singapore Med J; 1987 Dec; 28(6):577-8. PubMed ID: 2831627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.